4-[2-(1-哌啶基)乙基]苯酚结构式
|
常用名 | 4-[2-(1-哌啶基)乙基]苯酚 | 英文名 | 4-[2-(1-piperidyl)ethyl]phenol |
|---|---|---|---|---|
| CAS号 | 82966-19-6 | 分子量 | 205.29600 | |
| 密度 | 1.057g/cm3 | 沸点 | 330.2ºC at 760mmHg | |
| 分子式 | C13H19NO | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 156.2ºC |
本表展示该化学物质的中文名称、英文系统名、各类中文与英文别名信息。
| 中文名 | 4-[2-(1-哌啶基)乙基]苯酚 |
|---|---|
| 英文名 | 4-(2-piperidin-1-ylethyl)phenol |
本表包含该物质理化参数,如熔点、沸点、密度、溶解度、旋光性等理化指标,无数据项标记为N/A。
| 密度 | 1.057g/cm3 |
|---|---|
| 沸点 | 330.2ºC at 760mmHg |
| 分子式 | C13H19NO |
| 分子量 | 205.29600 |
| 闪点 | 156.2ºC |
| 精确质量 | 205.14700 |
| PSA | 23.47000 |
| LogP | 2.35850 |
| InChIKey | CEHROLDZFZBIBK-UHFFFAOYSA-N |
| SMILES | Oc1ccc(CCN2CCCCC2)cc1 |
本表提供该化合物公开报道的合成路线、反应条件、反应物与产物参考信息。
|
~99%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Barchuk, William T.; Dunford, Paul J.; Edwards, James P.; Fourie, Anne M.; Karlsson, Lars; Quan, Joanne M. Patent: US2008/194630 A1, 2008 ; Location in patent: Page/Page column 36 ; US 20080194630 A1 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Cheng et al. Journal of the American Chemical Society, 1951 , vol. 73, p. 4081,4082 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Kindler et al. Archiv der Pharmazie (Weinheim, Germany), 1950 , vol. 283, p. 184,187 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Shen, Yanhong; Sheng, Rong; Zhang, Jing; He, Qiaojun; Yang, Bo; Hu, Yongzhou Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 16 p. 7646 - 7653 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Cheng et al. Journal of the American Chemical Society, 1951 , vol. 73, p. 4081,4082 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Kindler et al. Archiv der Pharmazie (Weinheim, Germany), 1950 , vol. 283, p. 184,187 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Kindler et al. Archiv der Pharmazie (Weinheim, Germany), 1950 , vol. 283, p. 184,187 |
|
~%
4-[2-(1-哌啶基)乙基]苯酚 82966-19-6 |
| 文献:Kindler et al. Archiv der Pharmazie (Weinheim, Germany), 1950 , vol. 283, p. 184,187 |
本表列出该化学品对应的上游起始原料以及下游衍生产物清单。
| 4-[2-(1-哌啶基)乙基]苯酚上游产品 8 | |
|---|---|
| 4-[2-(1-哌啶基)乙基]苯酚下游产品 0 | |
本表记录该化合物靶点、体外体内实验、生物测定实验相关实验数据。
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in...
来源:NCGC
靶标:TDP1 protein [Homo sapiens]
External Id:TDP1100
|
|
实验名称:qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in...
来源:NCGC
靶标:TDP1 protein [Homo sapiens]
External Id:TDP1101
|
|
实验名称:Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Bas...
来源:Broad Institute
靶标:N/A
External Id:2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2
|
|
实验名称:Fluorescence polarization to screen for inhibitor that competite the binding of FadD2...
来源:Broad Institute
靶标:FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE)
External Id:2147-01_Inhibitor_SinglePoint_HTS_Activity
|
|
实验名称:Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfect...
来源:Broad Institute
靶标:N/A
External Id:Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition - 7011-01_Antagonist_SinglePoint_HTS_Activity
|
|
实验名称:High throughput screen for small molecule inhibitors of a hypoxia-regulated fluoresce...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1149-MLP
|
|
实验名称:qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Prima...
来源:NCGC
靶标:apical membrane antigen 1, AMA1 [Plasmodium falciparum 3D7]
External Id:AMA1100
|
本部分为该化合物相关常见问答,包含基础参数、性状、储存条件等高频咨询问题与对应答案。
| Q: 4-[2-(1-哌啶基)乙基]苯酚的InChIKey是什么? |
| A: 4-[2-(1-哌啶基)乙基]苯酚InChIKey为CEHROLDZFZBIBK-UHFFFAOYSA-N。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的SMILES表达式是什么? |
| A: 4-[2-(1-哌啶基)乙基]苯酚SMILES表达式为Oc1ccc(CCN2CCCCC2)cc1。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的英文名称是什么? |
| A: 4-[2-(1-哌啶基)乙基]苯酚英文名称为4-(2-piperidin-1-ylethyl)phenol。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的CAS号是多少? |
| A: 4-[2-(1-哌啶基)乙基]苯酚CAS号为82966-19-6。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的分子式是什么? |
| A: 4-[2-(1-哌啶基)乙基]苯酚分子式为C13H19NO。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的上游原料有哪些? |
| A: 4-[2-(1-哌啶基)乙基]苯酚相关上游原料(CAS):110-89-4;14140-15-9;702-23-8;82966-18-5;28145-35-9;6631-69-2;3544-25-0;104-47-2。 |
| Q: 82966-19-6的中文名称是什么? |
| A: 82966-19-6的中文名称为4-[2-(1-哌啶基)乙基]苯酚。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的极性表面积PSA是多少? |
| A: 4-[2-(1-哌啶基)乙基]苯酚极性表面积PSA为23.47000。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的沸点是多少? |
| A: 4-[2-(1-哌啶基)乙基]苯酚沸点为330.2ºC at 760mmHg。 |
| Q: 4-[2-(1-哌啶基)乙基]苯酚的LogP(油水分配系数)是多少? |
| A: 4-[2-(1-哌啶基)乙基]苯酚LogP(油水分配系数)为2.35850。 |